Inhaled Drug Delivery to 2022


Chart_Collage_160  Published March 2015  •  Catalog no. JDD353K  •  Price US $3,850


The upper airway diseases Asthma and COPD remain significant health challenges for both patients and clinicians.  Inhalers that combine two drugs indicated for treating upper airway diseases in one inhaler are gaining interest due to the complementary therapeutic effects of certain classes of drugs when taken together. Systemic delivery continues to represent an area of significant opportunity. Products and product candidates in this category include inhaled drugs for the treatment of such diverse conditions as pulmonary arterial hypertension, neurological disorders, hereditary diseases and pain management.

Bar_GraphReport Prospectus (Download PDF)

Blue document Report Order Form (Download PDF)


What You Will Learn

• Which therapeutic drugs are delivered via aerosol inhalers, dry powder inhalation and
nebulizers for upper respiratory conditions? For systemic delivery?
• What are the inhalable drugs currently in development, their formulation and device strategies, and targeted indication(s) and what are market prospects?
• What are the key inhalation device technologies for commercial and development-stage devices, and what are the product technology issues and related market factors?
• What are the current market dynamics of inhaled drug targeted disease segments, and what are the growth prospects and market potential for inhaled therapeutic drugs?
• What is the current market share for inhaled drugs by product? By supplier? What will it be in seven years?
• Who are the Inhaled drug product market participants, their products, market strategies, product development activity, and partners?


Summary of Contents

Executive Summary

The Orally Inhaled Drug Delivery Market
Therapeutic Targets
Upper Respiratory
Systemic Inhaled Delivery
Demand Drivers
Risk Factors

Competing Technologies
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers

Inhalation Technology & Product Development Factors
Formulation Factors
Drug Formulations
Formulation Technologies
Excipients and Release Profiles

Inhalation Device Design Factors
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers

Inhaler Performance Factors
Bioavailability
Dose Reproducibility
Active Compound Stability
Testing and Packaging

Inhalation Devices – Product & Device Assessments
Dry Powder inhalers
Metered Dose Inhalers
Nebulizers

Inhaled Drugs – Therapeutic Segment Analysis & Forecasts
Upper Respiratory Indications
Asthma
COPD
Systemic Drug Delivery
Bioterror
Cardiovascular Medicine
Pulmonary Hypertension
Diabetes
Hereditary Diseases
Cystic Fibrosis
Immunology
Infectious Diseases
Osteoporosis
Neurology
Oncology

Market Factors
Regulatory Issues
Patient Compliance
Healthcare Economics
Connected Devices

Market Sector Company Profiles